BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22189268)

  • 1. Splicing analysis of unclassified variants in COL2A1 and COL11A1 identifies deep intronic pathogenic mutations.
    Richards AJ; McNinch A; Whittaker J; Treacy B; Oakhill K; Poulson A; Snead MP
    Eur J Hum Genet; 2012 May; 20(5):552-8. PubMed ID: 22189268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep Intronic Sequence Variants in COL2A1 Affect the Alternative Splicing Efficiency of Exon 2, and May Confer a Risk for Rhegmatogenous Retinal Detachment.
    Spickett C; Hysi P; Hammond CJ; Prescott A; Fincham GS; Poulson AV; McNinch AM; Richards AJ; Snead MP
    Hum Mutat; 2016 Oct; 37(10):1085-96. PubMed ID: 27406592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited and de novo biallelic pathogenic variants in COL11A1 result in type 2 Stickler syndrome with severe hearing loss.
    Nixon T; Richards AJ; Lomas A; Abbs S; Vasudevan P; McNinch A; Alexander P; Snead MP
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1354. PubMed ID: 32578940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel deep intronic COL2A1 mutation in a family with early-onset high myopia/ocular-only Stickler syndrome.
    Sun W; Xiao X; Li S; Jia X; Zhang Q
    Ophthalmic Physiol Opt; 2020 May; 40(3):281-288. PubMed ID: 32196734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative splicing modifies the effect of mutations in COL11A1 and results in recessive type 2 Stickler syndrome with profound hearing loss.
    Richards AJ; Fincham GS; McNinch A; Hill D; Poulson AV; Castle B; Lees MM; Moore AT; Scott JD; Snead MP
    J Med Genet; 2013 Nov; 50(11):765-71. PubMed ID: 23922384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exon-Trapping Assay Improves Clinical Interpretation of
    Micale L; Morlino S; Schirizzi A; Agolini E; Nardella G; Fusco C; Castellana S; Guarnieri V; Villa R; Bedeschi MF; Grammatico P; Novelli A; Castori M
    Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33348901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All reported non-canonical splice site variants in GLA cause aberrant splicing.
    Okada E; Horinouchi T; Yamamura T; Aoto Y; Suzuki R; Ichikawa Y; Tanaka Y; Masuda C; Kitakado H; Kondo A; Sakakibara N; Ishiko S; Nagano C; Ishimori S; Usui J; Yamagata K; Matsuo M; Nozu K
    Clin Exp Nephrol; 2023 Sep; 27(9):737-746. PubMed ID: 37254000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stickler syndrome and the vitreous phenotype: mutations in COL2A1 and COL11A1.
    Richards AJ; McNinch A; Martin H; Oakhill K; Rai H; Waller S; Treacy B; Whittaker J; Meredith S; Poulson A; Snead MP
    Hum Mutat; 2010 Jun; 31(6):E1461-71. PubMed ID: 20513134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel pathogenic COL11A1/COL11A2 variants in Stickler syndrome detected by targeted NGS and exome sequencing.
    Acke FR; Malfait F; Vanakker OM; Steyaert W; De Leeneer K; Mortier G; Dhooge I; De Paepe A; De Leenheer EM; Coucke PJ
    Mol Genet Metab; 2014 Nov; 113(3):230-5. PubMed ID: 25240749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splicing and multifactorial analysis of intronic BRCA1 and BRCA2 sequence variants identifies clinically significant splicing aberrations up to 12 nucleotides from the intron/exon boundary.
    Whiley PJ; Guidugli L; Walker LC; Healey S; Thompson BA; Lakhani SR; Da Silva LM; ; Tavtigian SV; Goldgar DE; Brown MA; Couch FJ; Spurdle AB
    Hum Mutat; 2011 Jun; 32(6):678-87. PubMed ID: 21394826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding the phenotype spectrum associated with pathogenic variants in the COL2A1 and COL11A1 genes.
    Čopíková J; Paděrová J; Románková V; Havlovicová M; Balaščáková M; Zelinová M; Vejvalková Š; Simandlová M; Štěpánková J; Hořínová V; Kantorová E; Křečková G; Pospíšilová J; Boday A; Meszarosová AU; Turnovec M; Votýpka P; Lišková P; Kremlíková Pourová R
    Ann Hum Genet; 2020 Sep; 84(5):380-392. PubMed ID: 32427345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minigene Splicing Assays and Long-Read Sequencing to Unravel Pathogenic Deep-Intronic Variants in
    Tamayo A; Núñez-Moreno G; Ruiz C; Plaisancie J; Damian A; Moya J; Chassaing N; Calvas P; Ayuso C; Minguez P; Corton M
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole Exome Sequencing Reveals Novel PHEX Splice Site Mutations in Patients with Hypophosphatemic Rickets.
    Ma SL; Vega-Warner V; Gillies C; Sampson MG; Kher V; Sethi SK; Otto EA
    PLoS One; 2015; 10(6):e0130729. PubMed ID: 26107949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High efficiency of mutation detection in type 1 stickler syndrome using a two-stage approach: vitreoretinal assessment coupled with exon sequencing for screening COL2A1.
    Richards AJ; Laidlaw M; Whittaker J; Treacy B; Rai H; Bearcroft P; Baguley DM; Poulson A; Ang A; Scott JD; Snead MP
    Hum Mutat; 2006 Jul; 27(7):696-704. PubMed ID: 16752401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of
    Montalban G; Bonache S; Moles-Fernández A; Gisbert-Beamud A; Tenés A; Bach V; Carrasco E; López-Fernández A; Stjepanovic N; Balmaña J; Diez O; Gutiérrez-Enríquez S
    J Med Genet; 2019 Feb; 56(2):63-74. PubMed ID: 30472649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletions within COL11A1 in Type 2 stickler syndrome detected by multiplex ligation-dependent probe amplification (MLPA).
    Vijzelaar R; Waller S; Errami A; Donaldson A; Lourenco T; Rodrigues M; McConnell V; Fincham G; Snead M; Richards A
    BMC Med Genet; 2013 Apr; 14():48. PubMed ID: 23621912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of splicing mutations on NF2-transcripts: transcript analysis and information theoretic predictions.
    Ellis JR; Heinrich B; Mautner VF; Kluwe L
    Genes Chromosomes Cancer; 2011 Aug; 50(8):571-84. PubMed ID: 21563229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AG-exclusion zone revisited: Lessons to learn from 91 intronic NF1 3' splice site mutations outside the canonical AG-dinucleotides.
    Wimmer K; Schamschula E; Wernstedt A; Traunfellner P; Amberger A; Zschocke J; Kroisel P; Chen Y; Callens T; Messiaen L
    Hum Mutat; 2020 Jun; 41(6):1145-1156. PubMed ID: 32126153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rules and tools to predict the splicing effects of exonic and intronic mutations.
    Ohno K; Takeda JI; Masuda A
    Wiley Interdiscip Rev RNA; 2018 Jan; 9(1):. PubMed ID: 28949076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive characterisation of intronic mis-splicing mutations in human cancers.
    Jung H; Lee KS; Choi JK
    Oncogene; 2021 Feb; 40(7):1347-1361. PubMed ID: 33420369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.